bilaterals.org logo
bilaterals.org logo

intellectual property


Civil enforcement of IPR: Lessons of KORUS for RCEP
The provisions for civil enforcement are to ensure to the maximum extent the economic interests of IP holders. For the full compensation for them, KORUS intervenes the way to calculate the amount of damages.
Criminal enforcement of copyright and unintended consequences: Lessons of KORUS for RCEP
Soon after the signing of the Korea-US FTA (“KORUS”) in June 2007, South Korea experienced a dramatic increase of complaints of copyright crime from 2007.
Keep agriculture and dairy out of RCEP negotiations, farmers’ body tells government
The RCEP will destroy farm livelihoods especially in the domestic dairy sector.
Japan and US break new ground on free digital trade
Japanese and American trade negotiators have reached a broad agreement on the digital economy, in which digital products are tariff-free and businesses can host servers wherever they choose.
Vietnam: New free trade agreement with EU strengthens IP protection
Vietnam’s full compliance with the EVFTA will require a comprehensive review and amendment of its intellectual property law.
Trade negotiations and the triple trouble for health and the NHS
On Monday, the British parliament will debate whether the NHS should be included in US trade talks. Here’s how to decode the reassuring words we’ll no doubt hear from government.
Old wine in new bottles: Keep TRIPS-plus provisions out of the RCEP FTA!
Intellectual property barriers, which would hinder access to affordable medicines, have supposedly been removed from the draft RCEP free-trade agreement (FTA).
India protects drug, agriculture business at RCEP
Three harmful provisions concerning pharmaceuticals and agriculture which were part of the RCEP have been withdrawn.
Thai CSOs’ proposition against IP enforcement in the RCEP negotiation
FTA Watch would like to urge the Thai negotiation team for the RCEP to have a strong position to reject proposals on Intellectual Property Enforcement chapter.
NAFTA demolition better for PBI
USMCA, a modernization of the North American Free Trade Agreement, includes several positive changes for the seed industry.
NAFTA bill lets Trudeau cabinet wait and see what US Congress does Social Sharing
US Democrats fear higher drug prices, trying to change text of trade deal
Free trade can seriously damage your health
These practises open the door to Big Pharma companies and disastrous private health companies.
PepsiCo controversy: Globally, India has always refused to give in on IPR on plant varieties
The struggle for farmers’ rights over their seeds and planting materials is not playing out only in India – it’s a global phenomena.
Is Indonesia’s IPR Framework incompatible with RCEP?
On intellectual property rights, there’s a serious gap between domestic Indonesian law and the structures of the proposed RCEP
The African single market takes a step forward as the African Continental Free Trade Area Agreement becomes a reality
As a second step, negotiators will focus on rules pertaining to intellectual property rights, competition policy and investment, which they aim to finalise by June 2020.
2019: USTR takes aim at European countries over pharmaceutical pricing and reimbursement policies
In its latest report on foreign trade barriers, the USTR, prompted by the pharmaceutical industry, takes aim at the pharmaceutical pricing and reimbursement policies in the European Union.
PBO report shows that new NAFTA provisions threaten Pharmacare, says Council of Canadians
The Parliamentary Budget Officer (PBO) revealed that new intellectual property provisions in the Canada-United States-Mexico Agreement would cost Canadians as much as $169 million more per year for pharmaceutical drugs
Trump’s NAFTA 2.0 puts big pharma first, America second
The new version of NAFTA forbids the US Congress from curtailing Big Pharma’s patent monopolies on some of the world’s most expensive drugs.
Investment protection proposals under RCEP threaten India’s pharma industry
Free trade agreements like the RCEP will infringe on India’s intellectual property laws. India must stand its ground in the interest of public health.
Democrats cool toward NAFTA replacement, question labor standards
Several Democrats said a closed-door meeting between United States Trade Representative failed to ease their concerns about the new US-Mexico-Canada Agreement’s provisions on labor, biologic drugs and some other issues.